Momentum Stock Watch: Esperion Therapeutics Inc. (ESPR)
- Sunday, January 13, 2019, 10:08
- Stock Market, Stock Research
- Add a comment
Company Profile: |
Esperion Therapeutics, Inc., a lipid management company, focuses on developing and commercializing oral therapies for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C). Its lead product candidate is bempedoic acid/ezetimibe combination pill, a non-statin, orally available, LDL-C lowering therapy for patients with hypercholesterolemia and with atherosclerotic cardiovascular disease, and/or heterozygous familial hypercholesterolemia that is in Phase III long-term safety and tolerability study. Esperion Therapeutics, Inc. was founded in 2008 and is headquartered in Ann Arbor, Michigan. |
Recent News: |
Esperion Therapeutics (ESPR) announced that they have entered into a licensing agreement with Daiichi Sankyo Europe (DSE) providing DSE with exclusive rights to commercialize bempedoic acid and the bempedoic acid / ezetimibe combination pill in the European Economic Area and Switzerland. On Nov. 10, 2018, the company announced that the final Phase 3 results from Study 3 (1002-046, also known as CLEAR Serenity) were presented at the American Heart Association (AHA) Scientific Sessions in Chicago. |
Fundamental Analysis: |
Ninestocks analyzes several different financial aspects: Growth, Profitability, solvency and efficiency. |
Growth – Measures the growth of both the company’s income statement and cash flow. @@@@@ |
Profitability – Measures the historical price movement of the stock. @@@@@ |
Solvency – Measures the solvency of the company based on several ratios. @@@@@ |
Efficiency – Measures the strength and historic growth of a company’s return on invested capital. @@@@@ |
Conclusion: |
ESPR’s strengths can be seen in its strong growth compared with its peers. Technical indicators signal the bullish signs, as there is a bullish crossover in MACD and Stochastic oscillator and the RSI stands at 47.12 with positive bias. We rate Esperion Therapeutics Inc. (ESPR) a STRONG BUY. |
About the Author
Write a Comment
Gravatars are small images that can show your personality. You can get your gravatar for free today!
You must be logged in to post a comment.